These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37800478)

  • 1. α-Ketoglutarate-Dependent KDM6 Histone Demethylases and Interferon-Stimulated Gene Expression in Lupus.
    Montano EN; Bose M; Huo L; Tumurkhuu G; De Los Santos G; Simental B; Stotland AB; Wei J; Bairey Merz CN; Suda J; Martins G; Lalani S; Lawrenson K; Wang Y; Parker S; Venuturupalli S; Ishimori M; Wallace DJ; Jefferies CA
    Arthritis Rheumatol; 2024 Mar; 76(3):396-410. PubMed ID: 37800478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome.
    Pribadi C; Camp E; Cakouros D; Anderson P; Glackin C; Gronthos S
    Stem Cell Res Ther; 2020 Dec; 11(1):529. PubMed ID: 33298158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
    Yıldırım-Buharalıoğlu G
    Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.
    Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR
    Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer.
    Zhang J; Ying Y; Li M; Wang M; Huang X; Jia M; Zeng J; Ma C; Zhang Y; Li C; Wang X; Shu XS
    Theranostics; 2020; 10(22):10016-10030. PubMed ID: 32929331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
    Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced GATA4 expression in senescent systemic lupus erythematosus monocytes promotes high levels of IFNα production.
    Kuga T; Chiba A; Murayama G; Hosomi K; Nakagawa T; Yahagi Y; Noto D; Kusaoi M; Kawano F; Yamaji K; Tamura N; Miyake S
    Front Immunol; 2024; 15():1320444. PubMed ID: 38605949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JMJD3 as an epigenetic regulator in development and disease.
    Burchfield JS; Li Q; Wang HY; Wang RF
    Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.
    Dal-Pra S; Hodgkinson CP; Mirotsou M; Kirste I; Dzau VJ
    Circ Res; 2017 Apr; 120(9):1403-1413. PubMed ID: 28209718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM6 demethylase independent loss of histone H3 lysine 27 trimethylation during early embryonic development.
    Shpargel KB; Starmer J; Yee D; Pohlers M; Magnuson T
    PLoS Genet; 2014 Aug; 10(8):e1004507. PubMed ID: 25101834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3K27 demethylases are dispensable for activation of Polycomb-regulated injury response genes in peripheral nerve.
    Duong P; Ma KH; Ramesh R; Moran JJ; Won S; Svaren J
    J Biol Chem; 2021 Jul; 297(1):100852. PubMed ID: 34090875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
    Romero OA; Vilarrubi A; Alburquerque-Bejar JJ; Gomez A; Andrades A; Trastulli D; Pros E; Setien F; Verdura S; Farré L; Martín-Tejera JF; Llabata P; Oaknin A; Saigi M; Piulats JM; Matias-Guiu X; Medina PP; Vidal A; Villanueva A; Sanchez-Cespedes M
    Nat Commun; 2021 Jul; 12(1):4319. PubMed ID: 34262032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
    Lee SW; Park DY; Kim MY; Kang C
    Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.
    Smith S; Fernando T; Wu PW; Seo J; Ní Gabhann J; Piskareva O; McCarthy E; Howard D; O'Connell P; Conway R; Gallagher P; Molloy E; Stallings RL; Kearns G; Forbess L; Ishimori M; Venuturupalli S; Wallace D; Weisman M; Jefferies CA
    J Autoimmun; 2017 May; 79():105-111. PubMed ID: 28318807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.
    Liu J; Berthier CC; Kahlenberg JM
    Arthritis Rheumatol; 2017 Sep; 69(9):1840-1849. PubMed ID: 28564495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.
    Lee JY; Madany E; El Kadi N; Pandya S; Ng K; Yamashita M; Jefferies CA; Gibb DR
    Front Immunol; 2020; 11():584254. PubMed ID: 33101313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.